Ark Invest and Cathie Wood have made their entrance on the Italian Stock Exchange with the listing of three ETFs active in Milan. Among these, there is ARKK, the well-known flagship fund of ARK dedicated to innovation.
In addition to this, the ARK Genomic Revolution (ARKG) is also proposed, focused on genomic technologies.
Moreover, also ARK Artificial Intelligence & Robotics (ARKI), a new strategy dedicated to artificial intelligence and robotics, specifically developed for the European market. Let’s see all the details below.
Milan: Ark Invest’s ETFs now available on the stock exchange for investors in Italy
As anticipated, after the acquisition of Rize ETF by ARK Invest in 2023, ARK Invest Europe announces the debut on the Italian Stock Exchange of its first European UCITS ETFs, under the guidance of Cathie Wood.
As mentioned, this important launch includes the ARK Innovation UCITS ETF, ARK’s flagship strategy with $14 billion in assets, and the ARK Genomic Revolution UCITS ETF.
Furthermore, it also proposes a new strategy specifically created for the European market: the ARK Artificial Intelligence & Robotics UCITS ETF.
All these active management strategies focus on disruptive innovation and are classified as Article 8 under the SFDR.
So, after the recent listing on the London Stock Exchange, Deutsche Bӧrse Xetra and CBOE Amsterdam, these ETFs are also available on the Italian Stock Exchange. It is worth noting that all three ETFs have an annual management fee of 0.75%.
Cathie Wood’s considerations
Cathie Wood, CEO of ARK Invest, stated the following during the launch:
“We are excited to finally bring the ARK Innovation UCITS ETF, the ARK Genomic Revolution UCITS ETF, and the ARK Artificial Intelligence & Robotics UCITS ETF to Europe. Over the past ten years, we have observed a significant portion of our web traffic, subscribers, inquiries, and social media activity coming from Europe, confirming the great interest in ARK’s investment strategies in this market.”
According to ARK Invest, the launch of these ETFs is not only a response to the increasing demand, but also a testament to their commitment to the European market.
With a decade of experience behind it, ARK Invest brings some of its most popular and successful strategies to Europe, supported by a high-level distribution and product development team, composed of former founders and members of Rize ETF.
This European debut marks the beginning of a lasting partnership between ARK Invest and European investors. The company intends to continue innovating in the future, pursuing disruptive strategies aimed at transforming the investment landscape.
ARKK, ARKG and ARKI: the details of the three ETFs
The ARK Innovation ETF (“ARKK”) invests in companies that are at the forefront of disruptive innovation. These companies introduce new products and services that have the potential to change the world through technology.
ARKK focuses on sectors such as genomics, automation, transportation, energy, artificial intelligence, and financial technologies, among others.
With a $14 billion asset base and a 5-year time horizon, this ETF reflects Wood’s vision of a technologically advanced and more inclusive future.
The ARK Genomic Revolution ETF (“ARKG”) invests in companies that are leading or benefiting from advances in genomics and related technologies.
This ETF includes companies operating in the healthcare, IT, and agricultural sectors, developing products based on sequencing, genomic instrumentation, and molecular medicine.
ARKG is designed to capture opportunities in the genomic revolution, offering investors exclusive access to this rapidly growing sector.
The ARK Artificial Intelligence & Robotics ETF (“ARKI”), finally, is aimed at companies involved in artificial intelligence and robotics.
Unlike other European ETFs that are based on index replication, ARKI adopts an active strategy, selecting companies that lead innovation in AI, automation, and manufacturing.
This approach allows investors to benefit from the latest trends in these sectors. Cathie Wood concluded:
“The convergence of disruptive technologies is accelerating at an unprecedented pace. We believe this represents one of the most interesting investment opportunities of the moment.”
